Adjunctive corticosteroids in adults with bacterial meningitis
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Bacterial meningitis is a complex disorder in which neurologic injury is caused, in part, by the causative organism and, in part, by the host’s own inflammatory response. In studies of experimental bacterial meningitis, adjuvant treatment with corticosteroids, specifically dexamethasone, has beneficial effects. On the basis of these experimental studies, several clinical trials were undertaken to determine the effects of adjunctive corticosteroids in patients with bacterial meningitis. On the basis of overall benefit without detrimental effects by subgroup analysis, dexamethasone therapy should be initiated before or with the first dose of antibiotic and should be continued in most patients with community-acquired acute bacterial meningitis. For patients with a low suspicion of meningitis but an urgent need for antibiotics before cerebrospinal fluid can be obtained, we recommend initiation of treatment with dexamethasone, with discontinuation of dexamethasone therapy as soon as the diagnosis has been excluded.
References and Recommended Reading
Tauber MG, Khayam-Bashi H, Sande MA: Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. J Infect Dis 1985, 151:528–534.PubMed
Tunkel AR: Bacterial Meningitis. Philadelphia: Lippincott Williams & Wilkins; 2001.
van de Beek D, de Gans J, McIntyre P, Prasad K: Corticosteroids in acute bacterial meningitis. Cochrane Database Syst Rev 2003, CD004305.
de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347:1549–1556. The European Dexamethasone Study is a landmark study on adjunctive corticosteroids in adults with bacterial meningitis. This randomized clinical trial showed adjunctive dexamethasone treatment to be beneficial in adults with bacterial meningitis.PubMedCrossRef
van de Beek D, de Gans J, Spanjaard L, et al.: Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004, 351:1849–1859. The Dutch Meningitis Cohort is the first large prospective study of clinical features and prognostic factors in adults with bacterial meningitis. Patients were included in this study before routine dexamethasone use.PubMedCrossRef
Appelbaum PC: Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992, 15:77–83.PubMed
van de Beek D, de Gans J: Dexamethasone and pneumococcal meningitis. Ann Intern Med 2004, 141:327.PubMed
Weisfelt M, van de Beek D, de Haan RJ, de Gans J: Determinants for outcome in adults with bacterial meningitis treated with adjunctive dexamethasone. Intensive Care Med 2005, In press.
Bennett IL, Finland M, Hamburger M, et al.: The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963, 183:462–465.
Bhaumik S, Behari M: Role of dexamethasone as adjunctive therapy in acute bacterial meningitis in adults. Neurol India 1998, 46:225–228.
Gijwani D, Kumhar MR, Singh VB, et al.: Dexamethasone therapy for bacterial meningitis in adults: a double blind placebo control study. Neurol India 2002, 50:63–67.PubMed
Annane D, Bellissant E, Bollaert P, et al.: Corticosteroids for treating severe sepsis and septic shock. Cochrane Database Syst Rev 2004, CD002243.
Syrogiannopoulos GA, Lourida AN, Theodoridou MC, et al.: Dexamethasone therapy for bacterial meningitis in children: 2-versus 4-day regimen. J Infect Dis 1994, 169:853–858.PubMed
King SM, Law B, Langley JM, et al.: Dexamethasone therapy for bacterial meningitis: better never than late? Can J Infect Dis 1994, 5:210–215.
Cartwright K, Strang J, Gossain S, Begg N: Early treatment of meningococcal disease. BMJ 1992, 305:774.PubMed
Sorensen HT, Möller-Petersen J, Krarup HB, et al.: Early treatment of meningococcal disease. BMJ 1992, 305:774.PubMed
Sorensen HT, Steffensen FH, Schonheyder HC, et al.: Clinical management of meningococcal disease. Prospective international registration may be needed. BMJ 1998, 316:1016–1017.PubMed
Klugman KP, Friedland IR, Bradley JS: Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother 1995, 39:1988–1992.PubMed
Viladrich PF, Gudiol F, Linares J, et al.: Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrob Agents Chemother 1991, 35:2467–2472.PubMed
- Adjunctive corticosteroids in adults with bacterial meningitis
Current Infectious Disease Reports
Volume 7, Issue 4 , pp 285-291
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links